Clifford Chance advised Charme Capital Partners on the deal. Charme Capital Partners, a pan-European private equity firm, announced the acquisition of Centogene GmbH, a rare diseases...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Onex Corporation on the deal. Onex Corporation (TSX: ONEX) announced that Onex Partners Opportunities Fund has agreed to make a majority investment in...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Pegasus Digital Mobility Acquisition Corp. while Gleiss Lutz represented Gebr. Schmid GmbH. Gebr. Schmid GmbH (SCHMID Group) announced its planned listing on the New...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm Group on the deal. Neuraxpharm Group acquired two portfolios of established products from Sanofi which are marketed globally in more than...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Sanoma on the deal. Herbert Smith Freehills has advised Pearson plc. Sanoma, an innovative and agile learning and media company, acquired Pearson’s...
You must be a Standard 1 Year member to access this content.
REIUS. advised the founders of Redos Real Estate GmbH on the deal. Clifford Chance has advised European real estate investment manager Redevco. Redevco has acquired a...
You must be a Standard 1 Year member to access this content.
Clifford Chance, Morgan & Morgan, and Posse Herrera Ruiz advised Cinven on the deal. Hengeler Mueller advised Bayer on the transaction. Cinven signed an agreement with...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Clifford Chance, Hengeler Mueller, advised on the matter. Clifford Chance advised Cinven with a team including Howard Adler (Tax Corporate), Mark Aschenbrenner (Corporate M&A),...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Gilde Buy Out Partners, Taylor Wessing advised ]init[ AG and Noerr advised EMERAM Capital. Shearman & Sterling advised the shareholders of ]init[....
You must be a Standard 1 Year member to access this content.
IN BRIEF: Clifford Chance, Noerr, Taylor Wessing, advised on the matter. Clifford Chance advised Gilde Buy Out Partners with a team including Ines Keitel (Employment), Claudia...
You must be a Standard 1 Year member to access this content.
